Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Samsara Therapeutics
company
About
Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $10.31M
- Industries
- Biopharma,Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Samsara Therapeutics, Inc. is an R&D-stage biopharmaceutical platform company aiming to discover, develop and commercialize therapeutics for the treatment of unmet medical needs and age-related diseases. Samsara's platform is a pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend a healthy lifespan.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10.31M
Samsara Therapeutics has raised a total of
$10.31M
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2021 | Series A | $10.31M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Samsara Therapeutics is funded by 1 investors.
Korify Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Korify Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
